Next Article in Journal
Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo
Previous Article in Journal
Post-Translational Modification and Secretion of Azelaic Acid Induced 1 (AZI1), a Hybrid Proline-Rich Protein from Arabidopsis
Open AccessArticle

Individualized Follow-up of Pregnant Women with Asymptomatic Autoimmune Thyroid Disease

1
Obstetrics Gynecology Department, “Victor Babes” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Sq., Timisoara 300041, Romania
2
Surgery Department, “Victor Babes” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Sq., Timisoara 300041, Romania
3
Medical Informatics Department, “Victor Babes” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Sq., Timisoara 300041, Romania
4
Analytical Chemistry Department, “Victor Babes” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Sq., Timisoara 300041, Romania
5
Microbiology Department, “Victor Babes” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Sq., Timisoara 300041, Romania
*
Authors to whom correspondence should be addressed.
Academic Editor: Philip Newton Baker
Int. J. Mol. Sci. 2016, 17(1), 88; https://doi.org/10.3390/ijms17010088
Received: 29 November 2015 / Revised: 29 December 2015 / Accepted: 6 January 2016 / Published: 12 January 2016
(This article belongs to the Section Biochemistry)
Maternal hormones are essential for the normal fetal development during pregnancy. Autoimmune thyroid disease is a frequent pathology in our iodine replete region. The aim of this study is to evaluate the occurrence of subclinical hypothyroidism (SCH) in cases with known autoimmune thyroid disease, which were in a euthyroid state prior to pregnancy, and to assess the association between supplemental treatments administered and the outcome of the pregnancy. The study is a prospective interventional controlled study. The two cohorts comprise the interventional group, consisting of 109 pregnant women with known autoimmune asymptomatic thyroid disease, without any levothyroxine (LT4) treatment and an aged-matched control group, with an unknown thyroid disease. After the pregnancy, a monthly evaluation of TSH, FT3, and FT4 was performed. Offspring evaluation was made at birth time. 88.8% of the women developed SCH in the first four weeks of pregnancy. Average LT4 doses increased as the pregnancy progressed. The monthly adjustment was 12.5 or 25 μg. All SCH cases developed in the first trimester of pregnancy. There was no significant difference regarding the gestational week, weight, or length at birth between the interventional group and controls, when TSH values were in the optimal range, during the whole pregnancy. Premature birth was described in one case in the interventional group. View Full-Text
Keywords: autoimmune thyroid disease; subclinical hypothyroidism; pregnancy; follow-up; supplemental therapy autoimmune thyroid disease; subclinical hypothyroidism; pregnancy; follow-up; supplemental therapy
Show Figures

Graphical abstract

MDPI and ACS Style

Stoian, D.; Pantea, S.; Margan, M.; Timar, B.; Borcan, F.; Craina, M.; Craciunescu, M. Individualized Follow-up of Pregnant Women with Asymptomatic Autoimmune Thyroid Disease. Int. J. Mol. Sci. 2016, 17, 88.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop